NCT06859008
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +39 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
Explore clinical trials studying Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue trial results
Not Yet Recruiting
Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment
NCT07638722
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
Not specified
NCT02332980
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +48 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT05169658
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
NCT02339922
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States